Twist Bioscience (TWST) Cash & Current Investments (2018 - 2026)

Twist Bioscience has disclosed Cash & Current Investments across 9 years of filings, most recently posting $171.7 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 33.23% year-over-year to $171.7 million; the TTM figure through Mar 2026 stood at $171.7 million (down 33.23% YoY), while the FY2025 annual figure was $232.4 million, down 15.91% from the prior year.
• Cash & Current Investments fell to $171.7 million in Q1 2026, from $198.0 million in the prior quarter.
• Over the last five years, Cash & Current Investments for TWST reached as high as $573.9 million in Q1 2022 and fell as low as $171.7 million in Q1 2026.
• The 5-year median for Cash & Current Investments is $293.3 million (2024), against an average of $334.0 million.
• Annual changes were most pronounced in 2022 — Cash & Current Investments soared 45.34% — and 2023, when it sank 33.38%.
• A 5-year view of Cash & Current Investments shows it stood at $438.7 million in 2022, then retreated by 29.08% to $311.1 million in 2023, then fell by 12.96% to $270.8 million in 2024, then decreased by 26.91% to $198.0 million in 2025, then dropped by 13.26% to $171.7 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $171.7 million, $198.0 million, and $232.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.